Palisade Bio (PALI) Operating Expenses (2010 - 2026)

Palisade Bio (PALI) has 17 years of Operating Expenses data on file, last reported at $10.7 million in Q1 2026.

• Quarterly Operating Expenses rose 365.28% year-over-year to $10.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.5 million (up 96.31% YoY) and the FY2025 annual result came in at $18.1 million, up 21.52% from the prior year.
• Operating Expenses advanced to $10.7 million in Q1 2026 per PALI's latest filing, from $10.0 million in the prior quarter.
• Across five years, Operating Expenses topped out at $10.7 million in Q1 2026 and bottomed at $2.3 million in Q1 2025.
• The 5-year median for Operating Expenses is $3.6 million (2023), against an average of $4.3 million.
• The widest annual swing landed in 2022, when Operating Expenses sank 89.13%; it then soared 365.28% in 2026.
• Tracing PALI's Operating Expenses over 5 years: stood at $3.8 million in 2022, then decreased by 18.04% to $3.2 million in 2023, then climbed by 7.23% to $3.4 million in 2024, then surged by 195.12% to $10.0 million in 2025, then climbed by 7.68% to $10.7 million in 2026.
• Per Business Quant, the three latest PALI Operating Expenses figures stand at $10.7 million (Q1 2026), $10.0 million (Q4 2025), and $2.9 million (Q3 2025).

Peer Comparison